Spots Global Cancer Trial Database for Study to Find Maintenance Dose for Periodic Administration of ASP3550
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study to Find Maintenance Dose for Periodic Administration of ASP3550
Official Title: ASP3550 Phase II Study - A Maintenance-Dose-Finding Study of Three-Month Depot in Patients With Prostate Cancer -
Study ID: NCT01261572
Conditions
Interventions
Study Description
Brief Summary: To find effective doses of ASP3550 on the maintenance of serum testosterone suppression in patients with prostate cancer.
Detailed Description: ASP3550 is administered periodically to patients with prostate cancer. The primary efficacy variable is the effect of ASP3550 on the maintenance of serum testosterone suppression. In addition, the safety and pharmacokinetics of ASP3550 will be investigated.
Eligibility
Minimum Age: 20 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
, Chubu, , Japan
, Chugoku, , Japan
, Hokkaido, , Japan
, Kansai, , Japan
, Kantou, , Japan
, Kyusyu, , Japan
, Shiku, , Japan
, Touhoku, , Japan
Contact Details
Name: Use Central Contact
Affiliation: Astellas Pharma Inc
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
